Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Johnson & Johnson ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 USA

www.jnj.com P: 732-524-0400 F: 732-214-0332

Description:

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 368,832,320
Shares Outstanding, K 2,686,520
Annual Sales, $ 71,890 M
Annual Net Income, $ 16,540 M
Last Quarter Sales, $ 19,650 M
Last Quarter Net Income, $ 3,764 M
36-Month Beta 0.82
% of Insider Shareholders 0.19%
% of Institutional Shareholders 65.61%

Growth:

1-Year Total Return 22.06%
3-Year Total Return 26.83%
5-Year Total Return 96.89%
5-Year Revenue Growth 10.55%
5-Year Earnings Growth 34.60%
5-Year Dividend Growth 40.00%

Per-Share Information:

Most Recent Earnings 1.90 on 10/17/17
Next Earnings Date N/A
Earnings Per Share ttm 7.14
EPS Growth vs. Prev Qtr 3.83%
EPS Growth vs. Prev Year 13.10%
Annual Dividend Rate, $ 3.36
Annual Dividend Yield 2.43%
Most Recent Dividend 0.84 on 08/25/17
Next Ex-Dividends Date 11/27/17
Dividend Payable Date 12/12/17
Dividend Payout Ratio 45.16
Most Recent Split 2-1 on 06/13/01

JNJ Ratios

Ratio
Price/Earnings ttm 19.38
Price/Earnings forward 18.85
Price/Earnings to Growth 2.81
Return on Equity % 23.49
Return on Assets % 13.20
Profit Margin % 23.01
Debt/Equity 0.32
Price/Sales 5.17
Price/Cash Flow 16.71
Price/Book 5.02
Book Value/Share 27.56
Interest Coverage 21.92

JNJ Dividends

Date Value
08/25/17 $0.8400
05/25/17 $0.8400
02/24/17 $0.8000
11/18/16 $0.8000
08/19/16 $0.8000
05/20/16 $0.8000
02/19/16 $0.7500
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart